Kingfisher Capital LLC Amgen Inc Transaction History

Kingfisher Capital LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $1.8 Million - $2.16 Million	-10,334 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $8,001 - $9,379	-48 Reduced 0.46%	10,334 $1.9 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $7,053 - $7,951	39 Added 0.38%	10,382 $1.97 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $7,314 - $8,538	41 Added 0.4%	10,343 $2.01 Million
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $45,025 - $50,760	243 Added 2.42%	10,302 $2.14 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $137,489 - $154,430	-828 Reduced 7.61%	10,059 $1.86 Million
Q1 2018 May 16, 2018	BUY	$169.43 - $198.0 $54,387 - $63,558	321 Added 3.04%	10,887 $1.86 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $1,181 - $1,320	7 Added 0.07%	10,566 $1.84 Million
Q3 2017 Nov 06, 2017	SELL	$167.29 - $191.0 $62,399 - $71,243	-373 Reduced 3.41%	10,559 $1.97 Million
Q2 2017 Aug 15, 2017	BUY	N/A	10,932	10,932 $1.88 Million

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Kingfisher Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Kingfisher Capital LLC with notifications on news.